FitJoints: Getting Fit for Hip and Knee Replacement
Getting Fit for Hip and Knee Replacement: The FitJoints Multisite Randomized Controlled Trial of a Multi-modal Intervention in Frail Patients With Osteoarthritis
1 other identifier
interventional
192
1 country
4
Brief Summary
Total hip or knee replacement is an important and cost-effective surgical intervention to relieve pain and improve independence and function in patients with osteoarthritis. The number of people waiting for elective surgeries has spiked in the COVID-19 pandemic. Prior to COVID-19, up to 40% of patients receiving joint replacement were frail and this number is rapidly increasing with longer wait-times and deconditioning associated with COVID-19 physical distancing. There is an urgent need to be responsive to the evolving challenges of healthcare. The proposed study is the first multi-site randomized controlled trial (RCT) to examine whether a multimodal frailty reduction intervention before surgery will improve postsurgical outcomes for this population. The COVID-19 adapted hybrid model includes a multimodal frailty intervention that may be implemented either in person or virtually and is aligned with international consensus guidelines on frailty reduction. To utilize the FitJoints multimodal frailty intervention to build resilience of patients undergoing joint replacement surgery to improve post-operative outcomes. The investigators hypothesize the FitJoints multimodal frailty intervention, with exercise, nutrition and medication optimization, will reduce frailty and pain while improving function and quality of life. Building upon the success of the FitJoints feasibility study (n=69) in Hamilton, Ontario, in the proposed multi-site RCT (n=192), older adults (≥60 years) undergoing hip or knee joint replacement surgery who are frail will be randomized to either the 3 to 6-months of multimodal intervention or usual care until the date of their surgery at multiple sites (Hamilton Health Sciences \& St Joseph's Healthcare Hamilton, ON; London Health Science Centre, London, ON; Foothills Hospital, Calgary, AB),The FitJoints evidence-based, multimodal intervention includes a hybrid model that can be implemented either in person or virtually:
- 1.Physiotherapist supported multi-component exercise program
- 2.Nutrition and protein optimization including dietary counseling
- 3.Medication review with prescribing recommendations
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2022
Longer than P75 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 27, 2021
CompletedFirst Posted
Study publicly available on registry
October 29, 2021
CompletedStudy Start
First participant enrolled
June 14, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedJuly 1, 2025
June 1, 2025
3.7 years
September 27, 2021
June 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Between-group Difference in Physical Performance
Assessed by the Short Physical Performance Battery (SPPB), which consists of the following sub-components: * 4-meter walk test (walking speed): measured in seconds, scored 0 to 4 * Chair rise: the ability to rise from a chair without arms: measured in seconds, scored 0 to 4 * Standing balance test: measured in seconds, scored 0 to 4 Sub-component scores will be aggregated to produce an overall SPPB score, with higher scores indicating lower level of frailty \[range 0-12\].
3-months post-operative
Secondary Outcomes (13)
Between-group Difference in Frailty
3-months post-operative
Between-group Difference in Knee Function/Pain
3-months post-operative
Between-group Difference in Hip Function/Pain
3-months post-operative
Between-Group Difference in Instrumental Activities of Daily Living
3-months post-operative
Between-group Difference in Physical Activities of Daily Living
3-months post-operative
- +8 more secondary outcomes
Study Arms (2)
Usual Care
NO INTERVENTIONParticipants in the control arm will receive usual care which involves patient education that all participants who are scheduled for hip/knee replacement receive at the arthroplasty centre. This may include recommendations to attend fitness classes or discuss nutrition tips and smoking cessation initiatives with their family doctor or other healthcare provider before surgery.
FitJoints Multi-modal Intervention
ACTIVE COMPARATORInterventions
Exercise: The study physiotherapist will prescribe an exercise program tailored to the participant's individual ability and preference with functional movements to mimic activities of daily living. Nutritional consultation and protein supplement: The site research assistant will coach participants to improve their nutrition, determine their daily protein target, and provide educational tools on how to achieve their target. Protein supplements will be provided to participants. Vitamin D: Participants will be provided with vitamin D3 (1000 IU) tablets to reduce the risk of falls and to preserve muscle strength and functional ability. They will be instructed to take one tablet daily for the duration of the intervention period. Medication optimization: The study pharmacist will conduct a medication review and provide, if required, recommendations for medication optimization.
Eligibility Criteria
You may qualify if:
- Pre-frail (score of 1 or 2) or frail (score of 3-5)
- ≥ 60 years old
- Receiving elective unilateral total hip or knee replacement
- Waiting time for surgery is estimated to be between 4 to 15 months
You may not qualify if:
- Renal disorder
- A neuromuscular disorder
- Active cancer
- Inflammatory arthritis
- Unable to speak or understand English and has no caregiver for translation
- Participating in another trial that involves protein supplementation
- Participating in an exercise program
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- McMaster Universitylead
- Hamilton Health Sciences Corporationcollaborator
- St. Joseph's Health Care Londoncollaborator
- London Health Sciences Centrecollaborator
- Alberta Health servicescollaborator
Study Sites (4)
Foothill Medical Centre - Alberta Health Services
Calgary, Alberta, Canada
Juravinski Hospital - Hamilton Health Sciences
Hamilton, Ontario, Canada
St. Joseph's Healthcare
Hamilton, Ontario, Canada
University Hospital - London Health Sciences Centre
London, Ontario, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alexandra Papaioannou
McMaster University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Department of Medicine
Study Record Dates
First Submitted
September 27, 2021
First Posted
October 29, 2021
Study Start
June 14, 2022
Primary Completion
March 1, 2026
Study Completion
March 1, 2026
Last Updated
July 1, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share